acyclovir
Generic: acyclovir
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
asclemed usa, inc.
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-050
Product ID
76420-050_b01ced44-7b5d-5716-e053-2995a90a1263
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077309
Listing Expiration
2026-12-31
Marketing Start
2007-06-09
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420050
Hyphenated Format
76420-050
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA077309 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 15 TABLET in 1 BOTTLE (76420-050-15)
- 30 TABLET in 1 BOTTLE (76420-050-30)
- 60 TABLET in 1 BOTTLE (76420-050-60)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b01ced44-7b5d-5716-e053-2995a90a1263", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["e186fdc9-b60e-4280-8d60-36cae9f2838f"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (76420-050-15)", "package_ndc": "76420-050-15", "marketing_start_date": "20200925"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-050-30)", "package_ndc": "76420-050-30", "marketing_start_date": "20200925"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-050-60)", "package_ndc": "76420-050-60", "marketing_start_date": "20200925"}], "brand_name": "acyclovir", "product_id": "76420-050_b01ced44-7b5d-5716-e053-2995a90a1263", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "76420-050", "generic_name": "acyclovir", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA077309", "marketing_category": "ANDA", "marketing_start_date": "20070609", "listing_expiration_date": "20261231"}